Stockholders Approve Reverse Split and 200K Share Increase for Equity Plan

summarizeSummary

MetaVia Inc. shareholders approved a reverse stock split and an increase of 200,000 shares for the equity incentive plan, signaling continued efforts to manage its stock price and compensation needs amidst financial challenges.

check_boxKey Events · Corporate Governance and Compliance · MTVA

• Reverse Stock Split Approved

  Stockholders approved a reverse stock split in the range of 1-for-5 to 1-for-22, granting the Board discretion to implement it. This is a critical step for the company, likely aimed at maintaining its Nasdaq listing, following a previous reverse split in December 2025.

• Equity Incentive Plan Expanded

  An additional 200,000 shares were authorized for the 2022 Equity Incentive Plan. This represents a potential dilution of approximately 3.87% based on the current market valuation.

• Directors Re-elected

  D. Gordon Strickland and James P. Tursi, M.D. were re-elected as Class I directors to serve until the 2029 annual meeting.

• Auditor Ratified

  BDO USA, P.C. was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

auto_awesomeAnalysis · MTVA · Life Sciences

MetaVia Inc. stockholders approved a reverse stock split (1-for-5 to 1-for-22) to address its low share price, likely to maintain Nasdaq listing. This follows a previous reverse split in December 2025 and indicates ongoing challenges with its stock valuation. Additionally, shareholders approved an increase of 200,000 shares for the equity incentive plan, representing a potential dilution of approximately 3.87% based on the current market cap, which could further pressure existing shareholders.